| MicroRNA expression and association with clinicopathologic features in papillary thyroid cancer: a systematic review P Aragon Han, CH Weng, HT Khawaja, N Nagarajan, EB Schneider, ... Thyroid 25 (12), 1322-1329, 2015 | 85 | 2015 |
| Association of BRAFV600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four … P Aragon Han, H Kim, S Cho, R Fazeli, A Najafian, H Khawaja, ... Thyroid 26 (4), 532-542, 2016 | 71 | 2016 |
| Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy KRQ Lim, R Maruyama, Y Echigoya, Q Nguyen, A Zhang, H Khawaja, ... Proceedings of the National Academy of Sciences 117 (28), 16509-16515, 2020 | 49 | 2020 |
| Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis K Le, J Sun, H Khawaja, M Shibata, SB Maggirwar, MR Smith, M Gupta Blood Advances 5 (14), 2863-2878, 2021 | 23 | 2021 |
| Culture conditions affect expression of DUX4 in FSHD myoblasts SN Pandey, H Khawaja, YW Chen Molecules 20 (5), 8304-8315, 2015 | 20 | 2015 |
| PARP1 differentially interacts with promoter region of DUX4 gene in FSHD myoblasts V Sharma, SN Pandey, H Khawaja, KJ Brown, Y Hathout, YW Chen Journal of genetic syndromes & gene therapy 7 (4), 2016 | 18 | 2016 |
| Developing Antisense Oligonucleotides Therapies for Facioscapulohumeral Muscular Dystrophy YW Chen, A Zhang, S Sen Chandra, K Murphy, H Khawaja, KRQ Lim, ... MOLECULAR THERAPY 27 (4), 359-360, 2019 | | 2019 |
| DUX4 Knockdown with LNA and 2'-MOE Gapmers: Developing a Treatment for Facioscapulohumeral Muscular Dystrophy KR Lim, R Maruyama, Y Echigoya, Q Nguyen, H Khawaja, SC Sreetama, ... MOLECULAR THERAPY 27 (4), 380-380, 2019 | | 2019 |
| LNA and 2'-MOE Gapmer-Mediated Knockdown of DUX4 in In Vitro and In Vivo Models of Facioscapulohumeral Muscular Dystrophy KR Lim, R Maruyama, H Khawaja, T Jones, P Jones, YW Chen, T Yokota MOLECULAR THERAPY 26 (5), 117-118, 2018 | | 2018 |
| In vivo delivery of third generation oligonucleotides targeting DUX4 using a new mouse model of FSHD K Murphy, SN Pandey, H Khawaja, W Jiang, T Jones, P Jones, L Bagat, ... | | 2017 |
| 153. Third Generation Antisense Targeted to Double Homeobox Protein 4 (DUX4) Reduced DUX4 Expression and Improved Differentiation of FSHD Myoblasts SN Pandey, K Murphy, H Khawaja, M Putta, L Bhagat, S Agrawal, ... Molecular Therapy 24, S60-S61, 2016 | | 2016 |
| 84TH ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION P Laurberg, DC Berman, IB Pedersen, S Andersen, A Carlé, C Chen, ... Thyroid 24 (S1), P-1-A-123, 2014 | | 2014 |
